Erythropoietin attenuates acute kidney dysfunction in murine experimental sepsis by activation of the β-common receptor-Reference-Cited by-同舟云学术

Erythropoietin attenuates acute kidney dysfunction in murine experimental sepsis by activation of the β-common receptor

Published:2013-09 Issue:3 Volume:84 Page:482-490
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Coldewey Sina M.,Khan Areeg I.,Kapoor Amar,Collino Massimo,Rogazzo Mara,Brines Michael,Cerami Anthony,Hall Peter,Sheaff Michael,Kieswich Julius E.,Yaqoob Muhammed M.,Patel Nimesh S.A.,Thiemermann Christoph

Publisher

Elsevier BV

Subject

Nephrology

Reference64 articles.

1. Early goal-directed therapy in the treatment of severe sepsis and septic shock;Rivers;N Engl J Med,2001

2. Early interventions in severe sepsis and septic shock: a review of the evidence one decade later;Rivers;Minerva Anestesiol,2012

3. Mechanisms of sepsis-induced organ dysfunction;Abraham;Crit Care Med,2007

4. Sepsis and acute kidney injury;Zarjou;J Am Soc Nephrol,2011

5. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury;Mehta;Crit Care,2007

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum phosphate levels and the development of sepsis associated acute kidney injury: evidence from two independent databases;Frontiers in Medicine;2024-03-22

2. Effects of glutamine and n-3 polyunsaturated fatty acid mixed lipid emulsion supplementation of parenteral nutrition on sepsis score and bacterial clearance in early experimental sepsis;Clinical Nutrition ESPEN;2023-04

3. A small erythropoietin derived non-hematopoietic peptide reduces cardiac inflammation, attenuates age associated declines in heart function and prolongs healthspan;Frontiers in Cardiovascular Medicine;2023-01-18

4. Extremely Low Dose of Erythropoiesis-Stimulating Agent May Be Associated with Increased Mortality in Hemodialysis Patients;American Journal of Nephrology;2023

5. Efficacy and safety of erythropoietin in a chronic model of Inflammatory Bowel Disease;Biomedicine & Pharmacotherapy;2022-12